###### How are we working with this?
**Helping health systems with adopting innovation**
In 2021, Elekta formed a new department, Global Policy and Patient Access, to serve as a partner to decision makers, across the world, in building long-term sustainable healthcare systems. To Elekta, a system is only sustainable if it provides fair and adequate compensation so that new innovations which provide clear clinical value can emerge and be adopted.
Challenges differ between healthcare systems. Developed markets for example may have compensation schemes that economically disadvantage clinics that adopt new treatment schemes, such as hypofractionation, when reimbursing per completed fraction. In developing markets, patients might lack access to treatment altogether due to a range of factors.
To tackle these varying challenges, the department develops expertise on how healthcare systems are constructed, on how compensation and treatment guidelines are set, and what kind of questions researchers need to answer to help policy makers construct policies that lead to optimal patient outcomes, in an economically sustainable way.
To make sure this expertise reaches the right people, the department works with decision and policy makers to drive change. The aim is to ensure fair and adequate compensation for radiotherapy treatments, so that hospitals and clinicians working within healthcare systems can adopt new innovations that improve both patient outcomes and access to treatments.
The department also manages partnerships with organizations such as IAEA and WHO, societies like ESTRO Cancer Foundation and ASTRO, as well as global organizations like City Cancer Challenge, UICC and Global Coalition for Radiotherapy. Elekta engages with these organizations to raise public awareness around the need for, and importance of, radiotherapy as
###### Increased access in underserved markets by a sustainability- linked bond
of SEK 1.5 bn
For outcome 2021/22, see **[page 15][.]**
[...]